BioSpace News Archive

DarioHealth Corp. (Nasdaq: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company and member of the Digital Therapeutics Alliance (DTx), today announced its plan to present the results of a new Dario app user study at the upcoming annual conference of the American Association of Diabetes Educators (AADE) in Houston, Texas on August 9-12, 2019.

Paladina Health, a healthcare provider of direct primary care services, today announced the appointment of Kirk Rosin, CEBS, as chief revenue officer.

Soliton, Inc.,, a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center, announced that the company has completed their site initiation visit for the first site to be included in its upcoming expanded pivotal Cellulite Trial.

Billingsley has been on dual missions: Expand the $72 billion company and encourage tech and cannabis companies to employ more women in leadership roles.

Vizient, Inc. has released its July 2019 Drug Price Forecast projecting health systems, including inpatient and non-acute environments, can expect a 4.57 percent increase for pharmaceutical purchases made from Jan. 1, 2020 to Dec. 31, 2020.

Bio-Techne Corporation reported its financial results for the fourth quarter ended June 30, 2019.

Sage Therapeutics, a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, reported business highlights and financial results for the second quarter ended June 30, 2019.

BioLineRx Ltd. reports its financial results for the quarter ended June 30, 2019 and provides a corporate update.

Full results will be published prior to September 15, 2019, details for which will be provided in advance.